Geode Capital Management, LLC Assembly Biosciences, Inc. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.65 - $1.25 $82,382 - $158,427	126,742 Added 26.12%	612,006 $501,000
Q3 2023 Nov 13, 2023	SELL	$0.87 - $1.13 $19,474 - $25,295	-22,385 Reduced 4.41%	485,264 $431,000
Q2 2023 Aug 11, 2023	BUY	$0.81 - $1.15 $44,567 - $63,274	55,021 Added 12.16%	507,649 $583,000
Q4 2022 Feb 13, 2023	SELL	$1.09 - $1.52 $992 - $1,384	-911 Reduced 0.2%	452,628 $588,000
Q3 2022 Nov 14, 2022	BUY	$1.7 - $2.34 $100,223 - $137,954	58,955 Added 14.94%	453,539 $743,000

Q2 2022 Aug 12, 2022	BUY	$1.35 - $2.29 $22,036 - $37,379	16,323 Added 4.32%	394,584 $828,000
Q1 2022 May 13, 2022	SELL	$1.46 - $2.45 $200,170 - $335,902	-137,103 Reduced 26.6%	378,261 $779,000
Q4 2021 Feb 11, 2022	SELL	$2.13 - $3.46 $21,084 - $34,250	-9,899 Reduced 1.88%	515,364 $1.2 Million
Q3 2021 Nov 12, 2021	BUY	$3.14 - $3.9 $166,294 - $206,544	52,960 Added 11.21%	525,263 $1.83 Million
Q2 2021 Aug 13, 2021	SELL	$3.8 - $4.56 $702,213 - $842,656	-184,793 Reduced 28.12%	472,303 $1.83 Million
Q1 2021 May 12, 2021	BUY	$4.33 - $6.63 $893,049 - $1.37 Million	206,247 Added 45.75%	657,096 $3.02 Million
Q4 2020 Feb 12, 2021	SELL	$4.87 - $17.29 $37,518 - $133,202	-7,704 Reduced 1.68%	450,849 $2.73 Million
Q3 2020 Nov 13, 2020	BUY	$15.08 - $27.04 $192,239 - $344,705	12,748 Added 2.86%	458,553 $7.54 Million
Q2 2020 Aug 13, 2020	BUY	$14.57 - $23.96 $466,181 - $766,624	31,996 Added 7.73%	445,805 $10.4 Million
Q1 2020 May 14, 2020	BUY	$10.27 - $21.23 $761,654 - $1.57 Million	74,163 Added 21.84%	413,809 $6.14 Million
Q4 2019 Feb 13, 2020	BUY	$8.36 - $23.81 $389,408 - $1.11 Million	46,580 Added 15.89%	339,646 $6.95 Million
Q3 2019 Nov 12, 2019	BUY	$9.83 - $14.82 $47,292 - $71,299	4,811 Added 1.67%	293,066 $2.88 Million
Q2 2019 Aug 14, 2019	BUY	$12.9 - $20.8 $422,616 - $681,428	32,761 Added 12.82%	288,255 $3.89 Million
Q1 2019 May 14, 2019	BUY	$17.7 - $24.93 $485,422 - $683,705	27,425 Added 12.02%	255,494 $5.03 Million
Q4 2018 Feb 13, 2019	BUY	$19.05 - $36.45 $229,647 - $439,404	12,055 Added 5.58%	228,069 $5.16 Million
Q3 2018 Nov 13, 2018	BUY	$34.41 - $44.23 $1.69 Million - $2.18 Million	49,226 Added 29.51%	216,014 $8.02 Million
Q2 2018 Aug 14, 2018	SELL	$39.21 - $50.29 $103,514 - $132,765	-2,640 Reduced 1.56%	166,788 $6.54 Million
Q1 2018 May 15, 2018	BUY	$41.7 - $64.16 $83,525 - $128,512	2,003 Added 1.2%	169,428 $8.33 Million
Q4 2017 Feb 13, 2018	BUY	$28.58 - $49.91 $1.08 Million - $1.89 Million	37,953 Added 29.31%	167,425 $7.58 Million
Q3 2017 Nov 14, 2017	BUY	$23.08 - $34.92 $147,065 - $222,510	6,372 Added 5.18%	129,472 $4.52 Million
Q2 2017 Aug 14, 2017	BUY	N/A	123,100	123,100 $2.54 Million

Others Institutions Holding ASMB

# of Institutions

Shares Held

16.3K

Call Options Held

Put Options Held

ETF Managers Group, LLC Summit, NJ

16.3K
Shares

$223,841
0.0% of portfolio

View Full List

About ASSEMBLY BIOSCIENCES, INC.

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $665M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

More about ASMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account